Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CSL Behring
Pharma
As Pfizer bows out, CSL keeps hemophilia gene therapy hopes alive
A small patient population, a wait-and-see attitude and a “fairly significant” infrastructure barrier have slowed CSL's gene therapy rollout.
Angus Liu
Apr 11, 2025 10:32am
China cuts, CSL site closure and Kyowa deal—Fierce Pharma Asia
Nov 22, 2024 3:00am
CSL Behring cuts headcount by 65 at Illinois plant
Apr 15, 2024 1:08pm
CSL asks autoimmune patients what they want from therapies
Jan 16, 2024 11:14am
UK enlists CSL Seqirus for flu pandemic vaccine preparedness
Sep 26, 2023 10:55am
Horizon pips Roche to rare disease reputation crown, Pfizer dips
Aug 24, 2023 8:20am
.jpg?VersionId=pf5l0gVUHV36aNKY3vN8EUzYL8ntWwBo)
.jpg?VersionId=yHHyca0qReMvus_3Dwp6vVeww0aGoxLK)